NRC Health (NRC) Debt Components
- 2026-06-30: Secured Debt, CurrentUSD (m); Notes Payable, CurrentUSD $4.02M; Long-term Debt, Current MaturitiesUSD $4.02M; Long-term Debt, Excluding Current MaturitiesUSD $86.01M.
- 2026-03-31: Secured Debt, CurrentUSD $4.01M; Notes Payable, CurrentUSD $4.01M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD $74.02M.
- 2025-12-31: Secured Debt, CurrentUSD (m); Notes Payable, CurrentUSD $4.01M; Long-term Debt, Current MaturitiesUSD $4.01M; Long-term Debt, Excluding Current MaturitiesUSD $75.02M.
- 2025-12-31: Secured Debt, CurrentUSD $4.01M; Notes Payable, CurrentUSD (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m).
NRC Health Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Secured Debt, Current USD | Notes Payable, Current USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-term Debt, Fair Value USD | Notes Payable USD | Long-Term Debt, Maturity, after Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Line of Credit Facility, Remaining Borrowing Capacity USD | Debt Instrument, Face Amount USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Periodic Payment USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.02M | $4.02M | $86.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $4.01M | $4.01M | (m) | $74.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $4.01M | $4.01M | $75.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $4.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | (m) | (m) | (m) | $4.12M | $4.12M | $5.63M | $6.18M | $59.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $4.01M | $4.01M | (m) | $76.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $3.93M | $3.93M | (m) | $77.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $3.04M | $3.04M | (m) | $58.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $4.79M | $4.79M | (m) | $57.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | $4.84M | $4.94M | $53.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $3.72M | $3.72M | (m) | $44.91M | $48.74M | (m) | (m) | (m) | (m) | (m) | $48.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $7.57M | $7.57M | (m) | $25.66M | $33.30M | (m) | (m) | (m) | (m) | (m) | $32.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $7.50M | $7.50M | (m) | $27.57M | $35.17M | (m) | (m) | (m) | (m) | (m) | $34.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $7.21M | $7.21M | (m) | $29.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | $36.79M | (m) | (m) | (m) | (m) | (m) | $36.40M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | $7.25M | $7.72M | $7.99M | $13.83M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $4.67M | (m) | (m) | $18.94M | (m) | (m) | (m) | (m) | (m) | $18.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $4.61M | (m) | (m) | $20.08M | (m) | (m) | (m) | (m) | (m) | $19.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $4.55M | (m) | (m) | $21.20M | (m) | (m) | (m) | (m) | (m) | $20.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $4.49M | (m) | (m) | $22.32M | (m) | (m) | (m) | (m) | (m) | $21.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $4.53M | $4.76M | $5.01M | $5.27M | $2.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $4.43M | (m) | (m) | $23.41M | (m) | (m) | (m) | (m) | (m) | $22.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $4.39M | (m) | (m) | $24.49M | (m) | (m) | (m) | (m) | (m) | $24.36M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $4.33M | (m) | (m) | $25.56M | (m) | (m) | (m) | (m) | (m) | $25.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $4.28M | (m) | (m) | $26.62M | (m) | (m) | (m) | (m) | (m) | $27.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | $4.31M | $4.53M | $4.76M | $13.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $4.22M | (m) | (m) | $27.66M | (m) | (m) | (m) | (m) | (m) | $29.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $4.17M | (m) | (m) | $28.69M | (m) | (m) | (m) | (m) | (m) | $30.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $4.11M | $4.11M | (m) | $25.49M | $29.70M | (m) | (m) | (m) | (m) | (m) | $31.43M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $4.06M | (m) | (m) | $30.71M | (m) | (m) | (m) | (m) | (m) | $32.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $4.06M | (m) | (m) | $26.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | $4.09M | $4.31M | $4.53M | $4.76M | $13.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $4.01M | $4.01M | (m) | $27.58M | $31.71M | (m) | (m) | (m) | (m) | (m) | $34.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $3.97M | $3.97M | (m) | $28.63M | $32.68M | (m) | (m) | (m) | (m) | (m) | $35.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $4.63M | $4.63M | (m) | $28.59M | $33.32M | (m) | (m) | (m) | (m) | (m) | $35.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $4.38M | $4.38M | (m) | $29.80M | $34.28M | (m) | (m) | (m) | (m) | (m) | $35.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $4.42M | $4.92M | $5.17M | $19.78M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $4.13M | $4.13M | (m) | $30.98M | $35.23M | (m) | (m) | (m) | (m) | (m) | $36.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $3.89M | $3.89M | (m) | $32.14M | $36.16M | (m) | (m) | (m) | (m) | (m) | $37.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $3.71M | $3.71M | (m) | $33.22M | $37.08M | (m) | (m) | (m) | (m) | (m) | $37.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $3.67M | $3.67M | (m) | $34.18M | $37.97M | (m) | (m) | (m) | (m) | (m) | $38.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $4.42M | $4.92M | $5.17M | $19.78M | (m) | (m) | (m) | $3.71M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $3.62M | $3.62M | (m) | $35.11M | $38.90M | (m) | $3.71M | $4.42M | $4.92M | $5.17M | $38.93M | (m) | $19.78M | $901.00K | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $3.58M | $3.58M | (m) | $36.03M | $39.78M | (m) | $3.71M | $4.42M | $4.92M | $5.17M | $39.81M | (m) | $19.77M | $1.79M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $1.07M | $1.07M | (m) | (m) | $1.07M | (m) | (m) | (m) | (m) | (m) | $1.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $1.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $1.69M | (m) | (m) | $1.69M | (m) | (m) | (m) | (m) | (m) | $1.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $2.11M | (m) | (m) | $2.11M | (m) | (m) | (m) | (m) | (m) | $2.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $2.50M | (m) | (m) | $2.72M | (m) | (m) | (m) | (m) | (m) | $2.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $2.68M | $2.68M | $857.00K | $3.54M | (m) | (m) | (m) | (m) | (m) | $3.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | $2.68M | $857.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.50M | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $2.46M | (m) | (m) | $3.94M | (m) | (m) | (m) | (m) | (m) | $3.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | $2.44M | (m) | (m) | $4.55M | (m) | (m) | (m) | (m) | (m) | $4.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $2.42M | (m) | (m) | $5.15M | (m) | (m) | (m) | (m) | (m) | $5.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $2.40M | $2.40M | $3.34M | $5.74M | (m) | (m) | (m) | (m) | (m) | $5.71M | (m) | (m) | (m) | $6.50M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | $2.40M | $2.48M | $857.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $2.38M | (m) | (m) | $6.33M | (m) | (m) | (m) | (m) | (m) | $6.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $2.36M | (m) | (m) | $6.91M | (m) | (m) | (m) | (m) | (m) | $6.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $2.35M | (m) | (m) | $7.49M | (m) | (m) | (m) | (m) | (m) | $7.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $2.33M | $2.33M | $5.74M | $8.07M | (m) | (m) | (m) | (m) | (m) | $8.00M | (m) | (m) | (m) | $6.50M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | (m) | (m) | (m) | $2.33M | $2.40M | $2.48M | $857.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $2.31M | (m) | (m) | $8.64M | (m) | (m) | (m) | (m) | (m) | $8.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | $2.29M | (m) | (m) | $9.20M | (m) | (m) | (m) | (m) | (m) | $9.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $2.27M | (m) | (m) | (m) | $9.77M | (m) | (m) | (m) | (m) | (m) | $9.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $2.26M | $2.26M | $8.07M | $10.32M | (m) | (m) | (m) | (m) | (m) | $10.16M | (m) | (m) | (m) | $6.50M | (m) | (m) | (m) | (m) |
| 2013-12-31 | $2.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | $2.26M | $2.33M | $2.40M | $2.48M | $858.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $2.24M | (m) | (m) | (m) | $10.88M | (m) | (m) | (m) | (m) | (m) | $10.74M | $10.90M | (m) | (m) | (m) | $6.50M | (m) | 3.12% | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $6.50M | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 2 month · $212.47K |
| 2013-06-30 | $2.40M | (m) | (m) | (m) | $11.61M | (m) | (m) | (m) | (m) | (m) | $11.38M | $11.60M | (m) | (m) | (m) | $6.50M | (m) | 3.12% | (m) |
| 2013-05-09 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $212.47K |
| 2013-05-09 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $11.80M | (m) | (m) |
| 2013-05-08 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $11.80M | 3.79% | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.79% | (m) |
| 2013-03-31 | $12.11M | (m) | (m) | (m) | $12.11M | (m) | (m) | (m) | (m) | (m) | $12.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $12.44M | (m) | $12.44M | (m) | $12.44M | (m) | (m) | (m) | (m) | (m) | $12.49M | (m) | (m) | (m) | $6.50M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $-12.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $12.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $13.08M | (m) | (m) | (m) | $13.08M | (m) | (m) | (m) | (m) | (m) | $13.19M | (m) | (m) | (m) | $6.50M | $6.50M | (m) | (m) | (m) |
| 2012-06-30 | $2.09M | (m) | (m) | (m) | $13.55M | (m) | (m) | (m) | (m) | (m) | $13.68M | (m) | (m) | (m) | $6.50M | $6.50M | (m) | (m) | (m) |
| 2011-12-31 | $1.86M | $-1.86M | (m) | (m) | $14.49M | (m) | (m) | (m) | (m) | (m) | $14.50M | $14.49M | (m) | (m) | $6.50M | (m) | (m) | (m) | (m) |
| 2008-12-19 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $9.00M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |